Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompass Group Regulatory News (CPG)

Share Price Information for Compass Group (CPG)

Share Price is delayed by 15 minutes
Get Live Data
33.14    0.16 (0.49%)
Bid:
33.13
Ask:
33.16
Spread: 0.03 (0.091%)
Market Cap: $56.35b
CPG Live PriceLast checked at - London Stock Exchange

Intraday Compass Group Share Chart

Pre-Close Trading Update

30 Sep 2020 07:00

RNS Number : 5013A
Compass Group PLC
30 September 2020
 

Legal Entity Identifier (LEI): No. 2138008M6MH9OZ6U2T68

 

 

 

30 September 2020

 

Pre-Close Trading Update

 

This statement updates investors on the Group's progress in the current financial year, ahead of the announcement on 24 November 2020 of our results for the year to 30 September 2020.

 

Group

 

The Group's organic revenue performance in the fourth quarter improved as clients in Education and Business & Industry began to return to schools and offices in our main markets.

 

 

Organic revenue

 

Q3 2020

Q4 2020[1]

FY 20201

North America

(45)%

c(38)%

c(19)%

Europe

(53)%[2]

c(39)%

c(25)%

Rest of World

(21)%[3]

c(18)%

c(9)%

Group

(44)%

c(36)%

c(19)%

 

The reopening of units and initial increase in volumes, combined with positive contract renegotiations and a relentless focus on efficiencies are expected to improve the Group's fourth quarter operating margin to breakeven, before any contract impairments. We are reviewing our contract portfolio[4] and at this preliminary stage we estimate, subject to audit, that we will have to impair around £100 million1,[5] of contract assets. Including estimated contract impairments, the fourth quarter underlying operating margin is expected to be around (3)%1 (Q3 2020: (5.2)%)[6]. The full year underlying operating profit margin is expected to be around 3%1,[7].

 

 

Q4 20201

FY 20201

Underlying operating margin pre- impairments

c0%

c3.5%

Estimated contract impairments

c(3)%

c(0.5)%

Underlying operating margin after estimated impairments

c(3)%

c3%7

 

Resizing costs in the fourth quarter were around £90 million1, bringing total FY2020 resizing costs to around £130 million1. These costs have been excluded from underlying operating profit to avoid distorting the progress in the underlying operating margin.

 

Regions

 

Performance in North America improved as clients in Education began to re-open for the school year and Business & Industry slowly started to recover. Healthcare remained strong, whilst our Sports & Leisure business was still closed.

 

We have made some changes to our management structure in Europe. As of the fourth quarter, our Middle East business has been managed within our European business. Full restated numbers for Europe including the Middle East and Rest of World excluding the Middle East are included in the Appendix of this announcement.

 

In Europe - now including the Middle East - we saw continued good performance in Healthcare and a meaningful increase in clients reopening in both Business & Industry and Education across the region. Our Sports & Leisure sector remained mostly closed.

 

In Rest of World - now excluding the Middle East - we saw an improvement in Education in our Asia Pacific business, however we did not see a material change in reopening rate in the rest of the sectors around the region.

 

Tax

 

As a result of the distortive impact of unrelieved foreign taxes and other non-tax-deductible expenses against a low profit base, we expect the 2020 full year tax rate to be a few percentage points higher than the HY 2020 rate of 24%.

 

Capital expenditure

 

Capital expenditure was around £175 million1 in the fourth quarter, mostly contractually committed spend but also included investments to support new business wins in North America. FY 2020 capital expenditure is expected to be around £720 million1.

 

Financial position

 

Our liquidity remains strong and we expect our liquidity at 30 September 2020, to be around £5 billion1 (£2.8 billion in undrawn credit facilities, £600 million available CCFF limit and around £1.6 billion in cash1). Our solid financial position is allowing us to continue to invest in the business through the crisis to strengthen our competitive advantages and support our long-term growth prospects.

 

Currency

 

Trading results from our overseas operations are translated at the average exchange rates for the period. At current spot rates[8], foreign exchange translation is expected to reduce 2019 reported revenue and underlying operating profit by around £355 million and £28 million respectively.

 

Summary

 

We are pleased with our progress in the quarter and that the business is now at breakeven at a trading level. We continue to proactively manage the business, reducing our costs, rebuilding our margins and investing to strengthen our competitive advantages. However, the pace at which our revenues and margins will recover remains unclear, especially given the possible increase in lockdown measures in the Northern Hemisphere through the winter months.

 

Despite the current challenges, when looking further ahead, we remain excited about the significant structural market opportunity globally, and the return to organic revenue growth, margin improvement and returns to shareholders over time.

 

We will provide a further update on trading at our full year results on 24 November 2020.

 

 

 

Enquiries

 

Investors Sandra Moura, Agatha Donnelly & Helen Javanshiri +44 (0) 1932 573000

Press Tim Danaher & Fiona Micallef-Eynaud, Brunswick +44 (0) 207 404 5959

Website www.compass-group.com

 

 

 

APPENDIX

 

Regional Restatement

 

We have made minor changes to our regional reporting structure. Our Europe region now includes the Middle East which is now excluded from Rest of World. Our North America region remains unchanged. To enable comparison with prior periods we are providing restated 3 year historical figures for the new regional structure. While these restatements affect regional results, they do not affect the Group's overall income statement, balance sheet, or cash flow.

 

 

Reported figures £'s million

Full Year

 

Europe

 

ROW

 

 

 

 

 

2020

2019

2018

 

2020

2019

2018

 Revenue

Old

 

6,160

6,050

 

 

3,298

3,379

Net restatement

 

231

206

 

 

(231)

(206)

New

 

6,391

6,256

 

 

3,067

3,173

 

 

 

 

 

 

 

 

 

 

 Organic revenue growth

Old

 

5.1%

3.0%

 

 

2.4%

1.4%

New

 

5.2%

3.1%

 

 

2.0%

1.1%

 

 

 

 

 

 

 

 

 

 

 Operating profit

Old

.

389

414

 

 

264

257

Net restatement

 

32

23

 

 

(32)

(23)

New

 

421

437

 

 

232

234

 

 

 

 

 

 

 

 

 

 

 Margin

Old

 

6.3%

6.8%

 

 

8.0%

7.6%

New

 

6.6%

7.0%

 

 

7.6%

7.4%

 

 

 

 

 

 

 

 

 

 

 Cash flow

Old

 

380

420

 

 

269

187

Net restatement

 

25

21

 

 

(25)

(21)

New

 

405

441

 

 

244

166

 

 

 

 

 

 

 

 

 

 

 ROCE

Old

 

10.0%

10.9%

 

 

31.8%

29.8%

New

 

10.8%

11.6%

 

 

28.6%

27.7%

 

Reported figures in £'s million

Half Year

 

Europe

 

ROW

 

 

 

 

 

2020

2019

2018

 

2020

2019

2018

 Revenue

Old

3,061

3,130

3,072

 

1,474

1,647

1,688

Net restatement

124

114

100

 

(124)

(114)

(100)

New

3,185

3,244

3,172

 

1,350

1,533

1,588

 

 

 

 

 

 

 

 

 

 Organic revenue growth

Old

(4.3%)

6.4%

1.5%

 

3.1%

1.4%

1.7%

New

(3.9%)

6.4%

1.6%

 

2.6%

1.0%

1.6%

 

 

 

 

 

 

 

 

 

 Operating profit

Old

148

205

210

 

91

108

111

Net restatement

17

14

12

 

(17)

(14)

(12)

New

165

219

222

 

74

94

99

 

 

 

 

 

 

 

 

 

 Margin

Old

4.8%

6.5%

6.8%

 

6.2%

6.6%

6.6%

New

5.2%

6.8%

7.0%

 

5.5%

6.1%

6.2%

 

 

 

 

 

 

 

 

 

 Cash flow

Old

77

170

192

 

66

120

76

Net restatement

24

11

(0)

 

(24)

(11)

0

New

101

181

192

 

42

109

76

 

 

 

 

Note to Editors

 

a) Compass Group PLC is the world's leading food service company, which generated annual revenues of £25.2 billion in the year to 30 September 2019. The Company specialises in providing food and a range of support services across the core sectors of Business & Industry, Healthcare & Seniors, Education, Sports & Leisure and Defence, Offshore & Remote, with an established brand portfolio. 

 

b) Organic revenue growth, a term used throughout the announcement, is calculated by adjusting for acquisitions (excluding current period acquisitions and including a full period in respect of prior period acquisitions), disposals (excluded from both periods) and exchange rate movements (translating the prior period at current period exchange rates).

 

c) Forward looking statements

 

Certain information included in this announcement is forward-looking and involves risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied by forward-looking statements. Forward-looking statements cover all matters which are not historical facts and include, without limitation, projections relating to results of operations and financial conditions and the Company's plans and objectives for future operations, including, without limitation, discussions of expected future revenues, financing plans, expected expenditures and divestments, risks associated with changes in economic conditions, the strength of the foodservice and support services markets in the jurisdictions in which the Group operates, fluctuations in food and other product costs and prices and changes in exchange and interest rates. Forward-looking statements can be identified by the use of forward-looking terminology, including terms such as "believes", "estimates", "anticipates", "expects", "forecasts", "intends", "plans", "projects", "goal", "target", "aim", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology. Forward-looking statements are not guarantees of future performance. All forward-looking statements in this announcement are based upon information known to the Company on the date of this announcement. Accordingly, no assurance can be given that any particular expectation will be met and readers are cautioned not to place undue reliance on forward-looking statements, which speak only at their respective dates. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Other than in accordance with its legal or regulatory obligations (including under the UK Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority), the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Nothing in this announcement shall exclude any liability under applicable laws that cannot be excluded in accordance with such laws.

 

d) A copy of this release, together with all other recent announcements and presentations can be found on Compass Group's website at www.compass-group.com.

 

 

 


[1] Expected figures based on unaudited positions.

[2] Restated to include Middle East.

[3] Restated to exclude Middle East.

[4] As per IAS 36 - Impairment of assets and as per IAS 37 - Provisions, Contingent Liabilities and Contingent Assets.

[5] Of the £100m charge, around half is in North America and the other half in Europe.

[6] Excluding Q3 resizing costs of £42m.

[7] Excluding full year resizing costs of around £130m.

[8] Closing rates as at 25 September 2020.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKCBBOBKDACB
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
11th May 20267:00 amRNSHalf Year Results Announcement
1st May 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSChange in trading currency of Ordinary Shares
1st Apr 20267:00 amRNSTotal Voting Rights
18th Mar 20267:00 amRNSChange in trading currency of Ordinary Shares
6th Mar 202610:15 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
10th Feb 20262:00 pmRNSSterling Equivalent of Final Dividend
5th Feb 20262:42 pmRNSResult of AGM
5th Feb 20267:00 amRNSQ1 Trading Statement
2nd Feb 20267:00 amRNSTotal Voting Rights
20th Jan 202610:38 amRNSAnnual Financial Report 2025
15th Jan 202611:15 amRNSHolding(s) in Company
9th Jan 202611:45 amRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
17th Dec 202512:00 pmRNSAnnual Report 2025 and Notice of AGM 2026
8th Dec 20253:15 pmRNSDirector Declaration
5th Dec 20255:50 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20252:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSFull Year Results
3rd Nov 20257:00 amRNSTotal Voting Rights
1st Oct 20257:05 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSBlock listing Interim Review
26th Sep 20252:00 pmRNSBoard and Committee Changes
22nd Sep 20255:58 pmRNSHolding(s) in Company
12th Sep 20252:45 pmRNSDirector Declaration
1st Sep 20257:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTotal Voting Rights
22nd Jul 20257:00 amRNSQ3 Trading Update
22nd Jul 20257:00 amRNSCompass Group PLC agrees to acquire Vermaat Groep
15th Jul 20254:45 pmRNSSterling Equivalent of Interim Dividend
1st Jul 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTotal Voting Rights
14th May 20257:00 amRNSHalf Year Results Announcement
1st May 20257:00 amRNSTotal Voting Rights
2nd Apr 20252:30 pmRNSDirector Declaration
1st Apr 20259:00 amRNSBlock listing Interim Review
1st Apr 20257:00 amRNSTotal Voting Rights
21st Mar 20254:25 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTotal Voting Rights
13th Feb 20254:00 pmRNSDirector/PDMR Shareholding
11th Feb 20253:00 pmRNSSterling Equivalent of Final Dividend
6th Feb 20254:41 pmRNSResult of AGM
6th Feb 20257:00 amRNSTrading Statement
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 202511:30 amRNSAnnual Financial Report
2nd Jan 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.